DAFTAR PUSTAKA 1. Nurdjanah S. Sirosis hati. Dalam: Sudoyo WA

49

DAFTAR PUSTAKA

1. Nurdjanah S. Sirosis hati. Dalam: Sudoyo WA, Setiyohadi B, Alwi I, et al,

editor. Buku ajar ilmu penyakit dalam jilid I. Edisi keempat. Jakarta: Pusat

Penerbitan Departemen Ilmu Penyakit Dalam FK UI, 2007.

2. Thorn, Adams, Braunwald, Isselbacher, & Petersdorf. Harrison's Principles of

Internal Medicine. Edisi IX. Jakarta Utara: Penerbit Buku Kedokteran; 1991.

3. The Global Burden Of Deseases 2004 [database on the internet]. WHO. 2008

[cited 16 November 2013]. Available from: www.who.int/evidence/bod.

4. Liver cirrhosis mortality rates in Britain from 1950 to 2002 an analysis of

routine data [database on the internet]. Leon,D. 2006 [cited 2 Desember

2013]. Available from: http:// www.thelancet.com.

5. Statistics About Liver of Cirrhosis [database on the internet]. NCHS. 2003

[cited 5 November 2013]. Available from:

http://www.wrongdiagnosis.com/c/cirrhosis_of_the_liver/stats.htm.

6. National Vital Statistics Reports [database on the internet]. Xu dkk. 2010

[cited 16 Desember 2013]. Available from:

http://www.cdc.gov/nchs/data_access/Vitalstatsonline.htm.

7. Muttaqin, A., & Sari, K. Gangguan Gastrointestinal. Jakarta: Penerbit

Salemba Medika; 2011.

8. Farrell, G. C., 2008, Cirrhosis in Asians: Less common than in Europeans

Journal of Gastroenterology and Hepatology, Volume 23, Issue 4, pages 508–

511 http://onlinelibrary.wiley.com/doi.

9. Kusumobroto O Hernomo. Sirosis Hati dalam buku ajar Ilmu Penyakit Hati.

Edisi I. Jakarta: Jayabadi; 2007.

10. Karina. Faktor Risiko Kematian Penderita Sirosis Hati Di RSUP Dr. Kariadi

Semarang Tahun 2002–2006, Jurnal Media Medika Muda [internet]. 2007

[cited 2014 Maret 11]. Available from:

http://eprints.undip.ac.id/view/divisions/sch=5Fmed/2007.html#group_K.

11. Sulaiman A. Gasrtoenterologi Hepatologi. Jakarta: CV. Sagung Seto; 1997.

http://www.thelancet.com/

http://onlinelibrary.wiley.com/doi

50

12. Global Burden of Viral Hepatitis [database on the internet]. WHO Geneva.

2010 [cited 12 Desember 2013]. Available from: http://

www.who.int/evidence/bod.

13. Hepatitis B and HIV Coinfecton Clinical Protocol [database on the internet].

WHO European Region. 2010 [cited 16 Desember 2013].

14. Laporan Hasil Riset Kesehatan Dasar RISKESDAS Indonesia [database on

the internet]. Departemen Kesehatan. 2007 [ cited 2 Januari 2014].

15. Profil Kesehatan 2008 [database on the internet]. Departemen Kesehatan.

2009 [cited 2 Januari 2014]. Available from: http//www.depkes.go.id .

16. Setiawati, M. Perbandingan Validitas Maddrey’s Discriminant Function dan

Skor Child-Pugh dalam Memprediksi Ketahanan Hidup 12 Minggu pada

Pasien Sirosis Hepatis. Semarang: Fakultas Kedokteran Universitas

Diponegoro; 2009.

17. Deep vein thrombosis in patient with cirrhosis [database on the internet].

Lesmana, dkk. 2009 [cited 16 Januari 2014]. Available from:

http://www.who.int/research/en.

18. Simamora, C. T. Hubungan Komplikasi, Skor Child-Turcotte dan Usia Lanjut

Sebagai Faktor Resiko Kematian Pada Pasien Sirosis Hati di RSUD Dr.

Soedarso Pontianak. Pontianak; 2013.

19. Malau, A. S. Karakteristik Penderita Sirosis Hati Yang Dirawat Inap Di

Rumah Sakit Martha Friska Medan Tahun 2006-2010. Medan; 2011.

20. Report of The Regional Committee for the Eastern Mediterranean Fifty-sixth

Session Fez, Morocco 5–8 October 2009 [database on the internet]. Mohsni.

2009 [cited 6 Pebruari 2014]. Available from: http://search.who.int/.

21. Statistics by Country for Cirrhosis of the liver [database on the internet]. US

Census Bureau, International Data Base. 2005 [cited 11 Januari 2014].

Available from: http://www.cureresearch.com/c/cirrhosis_of_the_liver/stats-

country_ printer.htm.

22. Ndraha. The Indonesian Journal of Gastroenterology, Hepatology, and

Digestive Endoscopy. Volume 10, Number 3; 2009.

23. Hadi, S. Gastroenterologi. Bandung: Penerbit Alumni Bandung; 2002.

http://www.who.int/evidence/bod

http://www.cureresearch.com/c/cirrhosis_of_the_liver/stats-country_%20printer.htm

http://www.cureresearch.com/c/cirrhosis_of_the_liver/stats-country_%20printer.htm

51

24. Liver cirrhosis–Epidemiological and Clinical Aspects Department of Internal

Medicine Sahlgrenska University Hospital, Goteborg University, Sweden

[database on the internet]. Gunnarsdottir. 2008 [cited 3 Pebruari 2014].

Available from: www.gupea.ub.gu.se/bitstream/2077/10132/1/Ramen-Avh-

SAG.pdf.

25. Rasyid. Temuan Ultrasonografi Kanker Hati Hepatoseluler Hepatoma.

Majalah Kedokteran Nusantara. Volume 39 No 2; 2006.

26. Sulaiman A. Harapan Baru Dalam Penatalaksanaan Sirosis Hati, Dalam

Pertemuan Ilmiah Tahunan Perkembangan Muktahir Ilmu Penyakit Dalam.

Jakarta: Balai Penerbit FK UI; 2003.

27. Death Rates [database on the internet]. WHO. 2004 [cited 8 Pebruari 2014].

Available from: http://www.who.int.

28. Studi Penggunaan Obat Pada Pasien Sirosis Hepatik [database on the internet].

Rencianisari. 2008 [cited 4 Pebruari 2014]. Available from:

http://adln.lib.unair.ac.id/go.php?id=gdlhub-gdl-s1-2011-.

29. Percentage of total deaths, death rates, age-adjusted death rates for 2007,

percentage change in age-adjusted death rates in 2007 from 2006, and ratio of

age-adjusted death rates, by race and sex for the 15 leading causes of death

for the total population in 2007 [database on the internet]. National Vital

Statistics Reports. 2010 [cited 15 Pebruari 2014]. Available from:

http://www.cdc.gov/nchs.

30. Avunduk, C. Manual of Gastroenterology Diagnosis and Therapy. Edisi IV.

Philadelphia: Lippincott Williams & Wilkins; 2008.

31. Sherlock S, Dooley J. Disease of the liver and biliary system. Edisi IX.

Oxford: Blackwell Scientific Publications, 1993: 357-67.

32. Rigas B, Spiro HM. Clinical Gastroenterology: companion book. Edisi IV.

New York: Mc Graw Hill, 1995: 588-611.

33. Global Burden of Diseases in 2002 [database on the internet]. WHO Global.

2008 [cited 9 Pebruari 2014]. Available from: http://www.wpro.who.int.

http://www.who.int/

http://adln.lib.unair.ac.id/go.php?id=gdlhub-gdl-s1-2011-

52

34. Arguedes MR, Fallon MB. Cirrhosis of the liver and its complications. In:

Carpenter CCJ, Griggs RC, Loscalzo J, editors. Cecil essentials of medicine.

Edisi XI. Pennsylvania: Saunders, 2004: 411-7.

35. Price S.A. Patofisiologi konsep Klinis Proses-proses Penyakit, Edisi VI.

Jakarta: EGC; 2006.

36. Kayacetin E, Efe D, Dogan C. Portal and splenic hemodynamics in cirrhotic

patients: relationship between esophageal variceal bleeding and the severity

of hepatic failure. Journal of Gastroenterology, 2004; 39: 661-7.

37. Friedman SL, McQuaid KR, Grendell JH. Current diagnosis and treatment in

gastroenterology. 2nd ed. New York: Mc Graw Hill, 2003: 644-62.

38. Porth CM. Pathophysiology: concepts of altered health states. 5th ed.

Philadelphia, 1998: 761-6.

39. Weiss GR. Clinical oncology. Connecticut: Appleton & Lange; 1993.

40. Cardenas A, Arroyo V. Mechanism of water and sodium retension in

cirrhosis and the phatogenesis of ascites. Best Pract Res Clin Endokrinol

Metab 2003; 17: 607-22.

41. Cheney CP, Goldberg EM, Chopra S. Cirrhosis and portal hypertension: an

overview. In: Friedman LS, Keeffe EB, editors. Handbook of liver disease.

2nd ed. China: Churchill Livingstone, 2004: 125-37.

42. Gilroy J. Basic neurology. 3rd ed. New York: Mc Graw Hill, 2000: 517-8.

43. Hassan HA. Spontaneous Bacterial Peritonitis. Dalam: Adi S, editor. Naskah

lengkap pendidikan kedokteran berkelanjutan XVI. Surabaya: Laboratorium

SMF Penyakit Dalam FK Unair RSUD Dr. Sutomo, 2001: 41-59.

44. Hirlan. Nutrisi enteral dan parenteral pada penderita penyakit hati kronik.

Dalam: Soeroso S, Haryoko W, Setiati TE, Kosim HMS, Triwara B, editor.

Gizi klinik: Nutrisi enteral dan parenteral. Badan Penerbit Universitas

Diponegoro; 1994.

45. Doubatty, AC. 2009. Perbandingan validitas skor mayo end stage liver

disease dan skor child-pugh dalam memprediksi ketahanan hidup 12 minggu

pada pasien sirosis hepatis. Semarang: Universitas Diponegoro.

53

46. Shibli, AB; Tachauer, A; Mohanty, SR.; 2006, Outpatient Management of

Cirrhosis, Southern Medicaal Journal, 99 (6), 559-561.

47. Clinical profile of patients with cirrhosis of liver in a tertiary carehospital,

Dharan, Nepal [database on the internet]. Maskey R, Karki P, Ahmed S V,

Manandhar D N. 2011 [cited 3 Maret 2014]. Available from:

http://www.ncbi.nlm.nih.gov/pubmed/22364095.

48. Sarin SK, Chari S, Sundaram KR, Ahuja RK, Anand BS, Broor SL. Young

versus adult cirrhosis: a prospective comparative analysis of the clinical

profile, natural course and survival. Gut 1988; 29: 101-7.

49. Etiology of Liver Cirrhosis in Mexico [database on the internet]. Méndez-

Sánchez N, Aguilar-Ramírez JR, Reyes A, Dehesa M, Juárez A, Castañeda B,

et al. 2004 [cited 22 Juli 2014]. Available from:

http://new.medigraphic.com/cgibin/resumenMainI.cgi?IDARTICULO=12532.

50. Complications of liver cirrhosis [database on the internet]. Wittenburg H,

Tennert U, Berg T. 2011 [cited 22 Juli 2014]. Available from:

http://europepmc.org/abstract/MED/21611819.

http://new.medigraphic.com/cgibin/resumenMainI.cgi?IDARTICULO=12532

http://europepmc.org/abstract/MED/21611819

54

Lampiran 1. Analisis Univariat beberapa Variabel

NPar Tests

Statistics

303 245 259 226 303

2 60 46 79 2

54.17 4.4606 2.3448 8.1827 10.46

54.00 1.9800 2.3000 5.3000 9.00

11.755 5.92105 .60094 12.46432 7.626

16 .11 .90 -.90 0

81 36.31 4.66 106.30 48

Valid

Missing

N

Mean

Median

Std. Dev iation

Minimum

Maximum

Usia Bilirubin Total

Albumin

serum PPT

Lama

perawatan

One-Sample Kolmogorov-Smirnov Test

303 245 259 226 303

54.17 4.4606 2.3448 8.1827 10.46

11.755 5.92105 .60094 12.46432 7.626

.062 .231 .064 .239 .145

.062 .221 .064 .232 .145

-.055 -.231 -.040 -.239 -.101

1.080 3.620 1.023 3.589 2.522

.193 .000 .246 .000 .000

N

Mean

Std. Dev iation

Normal Parametersa,b

Absolute

Positive

Negative

Most Extreme

Dif f erences

Kolmogorov-Smirnov Z

Asy mp. Sig. (2-tailed)

Usia Bilirubin Total

Albumin

serum PPT

Lama

perawatan

Test distribution is Normal.a.

Calculated f rom data.b.

55

Frequency Table

Jenis kelamin

205 67,7 67,7 67,7

98 32,3 32,3 100,0

303 100,0 100,0

Laki-laki

Perempuan

Total

Valid

Frequency Percent Valid Percent

Cumulat iv e

Percent

Usia

10 3.3 3.3 3.3

21 6.9 6.9 10.2

79 26.1 26.1 36.3

104 34.3 34.3 70.6

59 19.5 19.5 90.1

30 9.9 9.9 100.0

303 100.0 100.0

< 31

31 - 40

41 - 50

51 - 60

61 - 70

> 70

Total

Valid


Cumulat iv e

Percent

HBV

184 60.7 60.7 60.7

119 39.3 39.3 100.0

303 100.0 100.0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

HCV

55 18.2 18.2 18.2

248 81.8 81.8 100.0

303 100.0 100.0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

56

NAFL

21 6.9 6.9 6.9

282 93.1 93.1 100.0

303 100.0 100.0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Alkohol

303 100.0 100.0 100.0TidakValid


Cumulativ e

Percent

Lain-lain

59 19.5 19.5 19.5

244 80.5 80.5 100.0

303 100.0 100.0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Klasifikasi CHILD-PUGH

15 5,0 6,4 6,4

75 24,8 32,1 38,5

144 47,5 61,5 100,0

234 77,2 100,0

69 22,8

303 100,0

A

B

C

Total

Valid

Sy stemMissing

Total


Cumulat iv e

Percent

57

Perdarahan var. Esof

59 19,5 19,5 19,5

244 80,5 80,5 100,0

303 100,0 100,0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Ensefalopati Hepatikum

66 21,8 21,8 21,8

237 78,2 78,2 100,0

303 100,0 100,0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Karsinoma Hepatoseluler

34 11,2 11,2 11,2

269 88,8 88,8 100,0

303 100,0 100,0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Sindr. Hepatorenal

5 1,7 1,7 1,7

298 98,3 98,3 100,0

303 100,0 100,0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

58

Hematemesis

79 26,1 26,1 26,1

224 73,9 73,9 100,0

303 100,0 100,0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Melena

85 28,1 28,1 28,1

218 71,9 71,9 100,0

303 100,0 100,0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Ascites

224 73,9 73,9 73,9

79 26,1 26,1 100,0

303 100,0 100,0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Peritonitis bakterial spontan

1 ,3 ,3 ,3

302 99,7 99,7 100,0

303 100,0 100,0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Gastropati HT Porta

39 12,9 12,9 12,9

264 87,1 87,1 100,0

303 100,0 100,0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

59

Efusi pleura

38 12,5 12,5 12,5

265 87,5 87,5 100,0

303 100,0 100,0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Pneumonia

37 12,2 12,2 12,2

266 87,8 87,8 100,0

303 100,0 100,0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

TB paru

5 1,7 1,7 1,7

298 98,3 98,3 100,0

303 100,0 100,0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Syok

7 2,3 2,3 2,3

296 97,7 97,7 100,0

303 100,0 100,0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

60

Sepsis

19 6,3 6,3 6,3

284 93,7 93,7 100,0

303 100,0 100,0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Penyakit ginjal

10 3,3 3,3 3,3

293 96,7 96,7 100,0

303 100,0 100,0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Penyakit jantung

3 1,0 1,0 1,0

300 99,0 99,0 100,0

303 100,0 100,0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Survival rate

60 19,8 19,8 19,8

243 80,2 80,2 100,0

303 100,0 100,0

Meninggal

Hidup

Total

Valid


Cumulat iv e

Percent

Perut membesar

111 36.4 36.4 36.4

194 63.6 63.6 100.0

305 100.0 100.0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

61

Nyeri perut

17 5.6 5.6 5.6

288 94.4 94.4 100.0

305 100.0 100.0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Berak darah

32 10.5 10.5 10.5

273 89.5 89.5 100.0

305 100.0 100.0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Muntah darah

63 20.7 20.7 20.7

242 79.3 79.3 100.0

305 100.0 100.0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Badan lemas

15 4.9 4.9 4.9

290 95.1 95.1 100.0

305 100.0 100.0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Penurunan kesadaran

18 5.9 5.9 5.9

287 94.1 94.1 100.0

305 100.0 100.0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

62

Mata kuning

13 4.3 4.3 4.3

292 95.7 95.7 100.0

305 100.0 100.0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Lain2

48 15.7 15.7 15.7

257 84.3 84.3 100.0

305 100.0 100.0

Ya

Tidak

Total

Valid


Cumulativ e

Percent

Ensefalopati

32 10.5 44.4 44.4

40 13.1 55.6 100.0

72 23.6 100.0

233 76.4

305 100.0

grade I-I I

grade III -IV

Total

Valid

Sy stemMissing

Total


Cumulat iv e

Percent

Ascites

180 59.0 80.4 80.4

44 14.4 19.6 100.0

224 73.4 100.0

81 26.6

305 100.0

ringan-sedang

berat

Total

Valid

Sy stemMissing

Total


Cumulat iv e

Percent

63

Lampiran 2. Analisis Bivariat beberapa Variabel terhadap Survival Rate

Jenis kelamin * Survival rate Crosstabulation

39 166 205

65,0% 68,3% 67,7%

12,9% 54,8% 67,7%

21 77 98

35,0% 31,7% 32,3%

6,9% 25,4% 32,3%

60 243 303

100,0% 100,0% 100,0%

19,8% 80,2% 100,0%

Count

% within Surv ival rate

% of Total

Count


% of Total

Count


% of Total

Laki-laki

Perempuan

Jenis kelamin

Total

Meninggal Hidup

Surv ival rate

Total

64

HBV * Survival rate Crosstabulation

35 149 184

58.3% 61.3% 60.7%

11.6% 49.2% 60.7%

25 94 119

41.7% 38.7% 39.3%

8.3% 31.0% 39.3%

60 243 303

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count


% of Total

Count


% of Total

Count


% of Total

Ya

Tidak

HBV

Total

Meninggal Hidup

Surv ival rate

Total

HCV * Survival rate Crosstabulation

8 47 55

13.3% 19.3% 18.2%

2.6% 15.5% 18.2%

52 196 248

86.7% 80.7% 81.8%

17.2% 64.7% 81.8%

60 243 303

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count


% of Total

Count


% of Total

Count


% of Total

Ya

Tidak

HCV

Total

Meninggal Hidup

Surv ival rate

Total

NAFL * Survival rate Crosstabulation

3 18 21

5.0% 7.4% 6.9%

1.0% 5.9% 6.9%

57 225 282

95.0% 92.6% 93.1%

18.8% 74.3% 93.1%

60 243 303

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count


% of Total

Count


% of Total

Count


% of Total

Ya

Tidak

NAFL

Total

Meninggal Hidup

Surv ival rate

Total

65

Alkohol * Survival rate Crosstabulation

60 243 303

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

60 243 303

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count


% of Total

Count


% of Total

TidakAlkohol

Total

Meninggal Hidup

Surv ival rate

Total

Lain-lain * Survival rate Crosstabulation

18 41 59

30.0% 16.9% 19.5%

5.9% 13.5% 19.5%

42 202 244

70.0% 83.1% 80.5%

13.9% 66.7% 80.5%

60 243 303

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count


% of Total

Count


% of Total

Count


% of Total

Ya

Tidak

Lain-lain

Total

Meninggal Hidup

Surv iv al rate

Total

66

Klasifikasi CHILD-PUGH * Survival rate Crosstabulation

0 15 15

,0% 8,2% 6,4%

,0% 6,4% 6,4%

4 71 75

7,7% 39,0% 32,1%

1,7% 30,3% 32,1%

48 96 144

92,3% 52,7% 61,5%

20,5% 41,0% 61,5%

52 182 234

100,0% 100,0% 100,0%

22,2% 77,8% 100,0%

Count


% of Total

Count


% of Total

Count


% of Total

Count


% of Total

A

B

C

Klasif ikasi

CHILD-PUGH

Total

Meninggal Hidup

Surv iv al rate

Total

67

Usia * Survival rate

Crosstab

1 9 10

2.0 8.0 10.0

1.7% 3.7% 3.3%

.3% 3.0% 3.3%

3 18 21

4.2 16.8 21.0

5.0% 7.4% 6.9%

1.0% 5.9% 6.9%

15 64 79

15.6 63.4 79.0

25.0% 26.3% 26.1%

5.0% 21.1% 26.1%

19 85 104

20.6 83.4 104.0

31.7% 35.0% 34.3%

6.3% 28.1% 34.3%

15 44 59

11.7 47.3 59.0

25.0% 18.1% 19.5%

5.0% 14.5% 19.5%

7 23 30

5.9 24.1 30.0

11.7% 9.5% 9.9%

2.3% 7.6% 9.9%

60 243 303

60.0 243.0 303.0

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

< 31

31 - 40

41 - 50

51 - 60

61 - 70

> 70

Usia

Total

Meninggal Hidup

Surv ival rate

Total

Chi-Square Tests

2.604a 5 .761

2.663 5 .752

1.882 1 .170

303

Pearson Chi-Square

Likelihood Ratio

Linear-by-Linear

Association

N of Valid Cases

Value df

Asy mp. Sig.

(2-sided)

2 cells (16.7%) have expected count less than 5. The

minimum expected count is 1.98.

a.

68

Efusi pleura * Survival rate

Crosstab

3 35 38

7.5 30.5 38.0

5.0% 14.4% 12.5%

1.0% 11.6% 12.5%

57 208 265

52.5 212.5 265.0

95.0% 85.6% 87.5%

18.8% 68.6% 87.5%

60 243 303

60.0 243.0 303.0

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Ya

Tidak

Ef usi pleura

Total

Meninggal Hidup

Surv ival rate

Total

Chi-Square Tests

3.879b 1 .049

3.069 1 .080

4.649 1 .031

.051 .032

3.866 1 .049

303

Pearson Chi-Square

Continuity Correctiona

Likelihood Ratio

Fisher's Exact Test

Linear-by-Linear

Association

N of Valid Cases

Value df

Asy mp. Sig.

(2-sided)

Exact Sig.

(2-sided)

Exact Sig.

(1-sided)

Computed only for a 2x2 tablea.

0 cells (.0%) have expected count less than 5. The minimum expected count is 7.

52.

b.

69

Pneumonia * Survival rate

Crosstab

15 22 37

7.3 29.7 37.0

25.0% 9.1% 12.2%

5.0% 7.3% 12.2%

45 221 266

52.7 213.3 266.0

75.0% 90.9% 87.8%

14.9% 72.9% 87.8%

60 243 303

60.0 243.0 303.0

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Ya

Tidak

Pneumonia

Total

Meninggal Hidup

Surv ival rate

Total

Chi-Square Tests

11.414b 1 .001

9.975 1 .002

9.780 1 .002

.002 .002

11.377 1 .001

303

Pearson Chi-Square


Likelihood Ratio

Fisher's Exact Test

Linear-by-Linear

Association

N of Valid Cases

Value df

Asy mp. Sig.

(2-sided)

Exact Sig.

(2-sided)

Exact Sig.

(1-sided)



33.

b.

70

TB paru * Survival rate

Crosstab

0 5 5

1.0 4.0 5.0

.0% 2.1% 1.7%

.0% 1.7% 1.7%

60 238 298

59.0 239.0 298.0

100.0% 97.9% 98.3%

19.8% 78.5% 98.3%

60 243 303

60.0 243.0 303.0

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Ya

Tidak

TB paru

Total

Meninggal Hidup

Surv ival rate

Total

Chi-Square Tests

1.255b 1 .263

.308 1 .579

2.227 1 .136

.587 .329

1.251 1 .263

303

Pearson Chi-Square


Likelihood Ratio

Fisher's Exact Test

Linear-by-Linear

Association

N of Valid Cases

Value df

Asy mp. Sig.

(2-sided)

Exact Sig.

(2-sided)

Exact Sig.

(1-sided)


2 cells (50.0%) have expected count less than 5. The minimum expected count is .

99.

b.

71

Syok * Survival rate

Crosstab

7 0 7

1.4 5.6 7.0

11.7% .0% 2.3%

2.3% .0% 2.3%

53 243 296

58.6 237.4 296.0

88.3% 100.0% 97.7%

17.5% 80.2% 97.7%

60 243 303

60.0 243.0 303.0

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Ya

Tidak

Sy ok

Total

Meninggal Hidup

Surv ival rate

Total

Chi-Square Tests

29.020b 1 .000

24.081 1 .000

23.359 1 .000

.000 .000

28.925 1 .000

303

Pearson Chi-Square


Likelihood Ratio

Fisher's Exact Test

Linear-by-Linear

Association

N of Valid Cases

Value df

Asy mp. Sig.

(2-sided)

Exact Sig.

(2-sided)

Exact Sig.

(1-sided)


1 cells (25.0%) have expected count less than 5. The minimum expected count is 1.

39.

b.

72

Sepsis * Survival rate

Crosstab

18 1 19

3.8 15.2 19.0

30.0% .4% 6.3%

5.9% .3% 6.3%

42 242 284

56.2 227.8 284.0

70.0% 99.6% 93.7%

13.9% 79.9% 93.7%

60 243 303

60.0 243.0 303.0

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Ya

Tidak

Sepsis

Total

Meninggal Hidup

Surv ival rate

Total

Chi-Square Tests

71.676b 1 .000

66.730 1 .000

55.730 1 .000

.000 .000

71.439 1 .000

303

Pearson Chi-Square


Likelihood Ratio

Fisher's Exact Test

Linear-by-Linear

Association

N of Valid Cases

Value df

Asy mp. Sig.

(2-sided)

Exact Sig.

(2-sided)

Exact Sig.

(1-sided)



76.

b.

73

Penyakit ginjal * Survival rate

Crosstab

4 6 10

2.0 8.0 10.0

6.7% 2.5% 3.3%

1.3% 2.0% 3.3%

56 237 293

58.0 235.0 293.0

93.3% 97.5% 96.7%

18.5% 78.2% 96.7%

60 243 303

60.0 243.0 303.0

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Ya

Tidak

Peny akit

ginjal

Total

Meninggal Hidup

Surv ival rate

Total

Chi-Square Tests

2.657b 1 .103

1.504 1 .220

2.231 1 .135

.114 .114

2.648 1 .104

303

Pearson Chi-Square


Likelihood Ratio

Fisher's Exact Test

Linear-by-Linear

Association

N of Valid Cases

Value df

Asy mp. Sig.

(2-sided)

Exact Sig.

(2-sided)

Exact Sig.

(1-sided)



98.

b.

74

Penyakit jantung * Survival rate

Crosstab

0 3 3

.6 2.4 3.0

.0% 1.2% 1.0%

.0% 1.0% 1.0%

60 240 300

59.4 240.6 300.0

100.0% 98.8% 99.0%

19.8% 79.2% 99.0%

60 243 303

60.0 243.0 303.0

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Ya

Tidak

Peny akit

jantung

Total

Meninggal Hidup

Surv ival rate

Total

Chi-Square Tests

.748b 1 .387

.019 1 .891

1.331 1 .249

1.000 .515

.746 1 .388

303

Pearson Chi-Square


Likelihood Ratio

Fisher's Exact Test

Linear-by-Linear

Association

N of Valid Cases

Value df

Asy mp. Sig.

(2-sided)

Exact Sig.

(2-sided)

Exact Sig.

(1-sided)



59.

b.

75

Perdarahan var. Esof * Survival rate

Crosstab

7 52 59

11.7 47.3 59.0

11.7% 21.4% 19.5%

2.3% 17.2% 19.5%

53 191 244

48.3 195.7 244.0

88.3% 78.6% 80.5%

17.5% 63.0% 80.5%

60 243 303

60.0 243.0 303.0

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Ya

Tidak

Perdarahan

var. Esof

Total

Meninggal Hidup

Surv ival rate

Total

Chi-Square Tests

2.907b 1 .088

2.319 1 .128

3.197 1 .074

.102 .059

2.897 1 .089

303

Pearson Chi-Square


Likelihood Ratio

Fisher's Exact Test

Linear-by-Linear

Association

N of Valid Cases

Value df

Asy mp. Sig.

(2-sided)

Exact Sig.

(2-sided)

Exact Sig.

(1-sided)



68.

b.

76

Ensefalopati Hepatikum * Survival rate

Crosstab

41 25 66

13.1 52.9 66.0

68.3% 10.3% 21.8%

13.5% 8.3% 21.8%

19 218 237

46.9 190.1 237.0

31.7% 89.7% 78.2%

6.3% 71.9% 78.2%

60 243 303

60.0 243.0 303.0

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Ya

Tidak

Ensef alopati

Hepatikum

Total

Meninggal Hidup

Surv ival rate

Total

Chi-Square Tests

95.157b 1 .000

91.781 1 .000

81.663 1 .000

.000 .000

94.843 1 .000

303

Pearson Chi-Square


Likelihood Ratio

Fisher's Exact Test

Linear-by-Linear

Association

N of Valid Cases

Value df

Asy mp. Sig.

(2-sided)

Exact Sig.

(2-sided)

Exact Sig.

(1-sided)



07.

b.

77

Karsinoma Hepatoseluler * Survival rate

Crosstab

5 29 34

6.7 27.3 34.0

8.3% 11.9% 11.2%

1.7% 9.6% 11.2%

55 214 269

53.3 215.7 269.0

91.7% 88.1% 88.8%

18.2% 70.6% 88.8%

60 243 303

60.0 243.0 303.0

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Ya

Tidak

Karsinoma Hepatoseluler

Total

Meninggal Hidup

Surv ival rate

Total

Chi-Square Tests

.626b 1 .429

.317 1 .573

.668 1 .414

.502 .296

.624 1 .429

303

Pearson Chi-Square


Likelihood Ratio

Fisher's Exact Test

Linear-by-Linear

Association

N of Valid Cases

Value df

Asy mp. Sig.

(2-sided)

Exact Sig.

(2-sided)

Exact Sig.

(1-sided)



73.

b.

78

Sindr. Hepatorenal * Survival rate

Crosstab

2 3 5

1.0 4.0 5.0

3.3% 1.2% 1.7%

.7% 1.0% 1.7%

58 240 298

59.0 239.0 298.0

96.7% 98.8% 98.3%

19.1% 79.2% 98.3%

60 243 303

60.0 243.0 303.0

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Ya

Tidak

Sindr. Hepatorenal

Total

Meninggal Hidup

Surv ival rate

Total

Chi-Square Tests

1.306b 1 .253

.333 1 .564

1.093 1 .296

.258 .258

1.302 1 .254

303

Pearson Chi-Square


Likelihood Ratio

Fisher's Exact Test

Linear-by-Linear

Association

N of Valid Cases

Value df

Asy mp. Sig.

(2-sided)

Exact Sig.

(2-sided)

Exact Sig.

(1-sided)



99.

b.

79

Hematemesis * Survival rate

Crosstab

17 62 79

15.6 63.4 79.0

28.3% 25.5% 26.1%

5.6% 20.5% 26.1%

43 181 224

44.4 179.6 224.0

71.7% 74.5% 73.9%

14.2% 59.7% 73.9%

60 243 303

60.0 243.0 303.0

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Ya

Tidak

Hematemesis

Total

Meninggal Hidup

Surv ival rate

Total

Chi-Square Tests

.198b 1 .656

.079 1 .779

.196 1 .658

.743 .384

.198 1 .657

303

Pearson Chi-Square


Likelihood Ratio

Fisher's Exact Test

Linear-by-Linear

Association

N of Valid Cases

Value df

Asy mp. Sig.

(2-sided)

Exact Sig.

(2-sided)

Exact Sig.

(1-sided)



64.

b.

80

Melena * Survival rate

Crosstab

18 67 85

16.8 68.2 85.0

30.0% 27.6% 28.1%

5.9% 22.1% 28.1%

42 176 218

43.2 174.8 218.0

70.0% 72.4% 71.9%

13.9% 58.1% 71.9%

60 243 303

60.0 243.0 303.0

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Ya

Tidak

Melena

Total

Meninggal Hidup

Surv ival rate

Total

Chi-Square Tests

.141b 1 .708

.046 1 .830

.139 1 .709

.749 .410

.140 1 .708

303

Pearson Chi-Square


Likelihood Ratio

Fisher's Exact Test

Linear-by-Linear

Association

N of Valid Cases

Value df

Asy mp. Sig.

(2-sided)

Exact Sig.

(2-sided)

Exact Sig.

(1-sided)



83.

b.

81

Ascites * Survival rate

Crosstab

47 177 224

44.4 179.6 224.0

78.3% 72.8% 73.9%

15.5% 58.4% 73.9%

13 66 79

15.6 63.4 79.0

21.7% 27.2% 26.1%

4.3% 21.8% 26.1%

60 243 303

60.0 243.0 303.0

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Ya

Tidak

Ascites

Total

Meninggal Hidup

Surv ival rate

Total

Chi-Square Tests

.753b 1 .385

.495 1 .482

.777 1 .378

.417 .243

.751 1 .386

303

Pearson Chi-Square


Likelihood Ratio

Fisher's Exact Test

Linear-by-Linear

Association

N of Valid Cases

Value df

Asy mp. Sig.

(2-sided)

Exact Sig.

(2-sided)

Exact Sig.

(1-sided)



64.

b.

82

Peritonitis bakterial spontan * Survival rate

Crosstab

1 0 1

.2 .8 1.0

1.7% .0% .3%

.3% .0% .3%

59 243 302

59.8 242.2 302.0

98.3% 100.0% 99.7%

19.5% 80.2% 99.7%

60 243 303

60.0 243.0 303.0

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Ya

Tidak

Peritonitis bakterial

spontan

Total

Meninggal Hidup

Surv ival rate

Total

Chi-Square Tests

4.063b 1 .044

.576 1 .448

3.252 1 .071

.198 .198

4.050 1 .044

303

Pearson Chi-Square


Likelihood Ratio

Fisher's Exact Test

Linear-by-Linear

Association

N of Valid Cases

Value df

Asy mp. Sig.

(2-sided)

Exact Sig.

(2-sided)

Exact Sig.

(1-sided)



20.

b.

83

Gastropati HT Porta * Survival rate

Crosstab

5 34 39

7.7 31.3 39.0

8.3% 14.0% 12.9%

1.7% 11.2% 12.9%

55 209 264

52.3 211.7 264.0

91.7% 86.0% 87.1%

18.2% 69.0% 87.1%

60 243 303

60.0 243.0 303.0

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Count

Expected Count


% of Total

Ya

Tidak

Gastropati

HT Porta

Total

Meninggal Hidup

Surv ival rate

Total

Chi-Square Tests

1.374b 1 .241

.916 1 .339

1.503 1 .220

.288 .170

1.369 1 .242

303

Pearson Chi-Square


Likelihood Ratio

Fisher's Exact Test

Linear-by-Linear

Association

N of Valid Cases

Value df

Asy mp. Sig.

(2-sided)

Exact Sig.

(2-sided)

Exact Sig.

(1-sided)



72.

b.

84

Ensefalopati * Survival rate Crosstabulation

5 27 32

12.5% 84.4% 44.4%

6.9% 37.5% 44.4%

35 5 40

87.5% 15.6% 55.6%

48.6% 6.9% 55.6%

40 32 72

100.0% 100.0% 100.0%

55.6% 44.4% 100.0%

Count


% of Total

Count


% of Total

Count


% of Total

grade I-II

grade III-IV

Ensef alopati

Total

Meninggal Hidup

Surv iv al rate

Total

Ascites * Survival rate Crosstabulation

36 143 179

76.6% 81.3% 80.3%

16.1% 64.1% 80.3%

11 33 44

23.4% 18.8% 19.7%

4.9% 14.8% 19.7%

47 176 223

100.0% 100.0% 100.0%

21.1% 78.9% 100.0%

Count


% of Total

Count


% of Total

Count


% of Total

ringan-sedang

berat

Ascites

Total

Meninggal Hidup

Surv ival rate

Total

85

Klasifikasi CHILD-PUGH * Survival rate

Tahun * Survival rate Crosstabulation

22 90 112

36.7% 37.0% 37.0%

7.3% 29.7% 37.0%

22 101 123

36.7% 41.6% 40.6%

7.3% 33.3% 40.6%

16 52 68

26.7% 21.4% 22.4%

5.3% 17.2% 22.4%

60 243 303

100.0% 100.0% 100.0%

19.8% 80.2% 100.0%

Count


% of Total

Count


% of Total

Count


% of Total

Count


% of Total

2010

2011

2012

Tahun

Total

Meninggal Hidup

Surv ival rate

Total

Crosstab

0 15 15

.0% 8.2% 6.4%

.0% 6.4% 6.4%

4 71 75

7.7% 39.0% 32.1%

1.7% 30.3% 32.1%

48 96 144

92.3% 52.7% 61.5%

20.5% 41.0% 61.5%

52 182 234

100.0% 100.0% 100.0%

22.2% 77.8% 100.0%

Count


% of Total

Count


% of Total

Count


% of Total

Count


% of Total

A

B

C

Klasif ikasi

CHILD-PUGH

Total

Meninggal Hidup

Surv iv al rate

Total

86

Chi-Square Tests

26.949a 2 .000

33.354 2 .000

24.502 1 .000

234

Pearson Chi-Square

Likelihood Ratio

Linear-by-Linear

Association

N of Valid Cases

Value df

Asy mp. Sig.

(2-sided)

1 cells (16.7%) have expected count less than 5. The

minimum expected count is 3.33.

a.

87

Lampiran 3. Tabel Frekuensi dari beberapa Variabel

Variabel Frekuensi Prosentase

Jenis kelamin

Laki-laki 205 67,7

Perempuan 98 32,3

Usia

< 31 tahun 10 3,3

31 – 40 tahun 21 6,9

41 – 50 tahun 79 26,1

51 – 60 tahun 104 34,3

61 – 70 tahun 59 19,5

> 70 tahun 30 9,9

Keluhan utama

Perut membesar 111 36,4

Nyeri perut 17 5,6

Berak darah 32 10,5

Muntah darah 63 20,7

Badan lemas 15 4,9

Penurunan kesadaran 18 5,9

Mata kuning 13 4,3

Lain2 48 15,7

Etiologi

Virus

HBV 184 60,7

HCV 55 18,2

HBV dan HCV 17 30,9

Non Virus

NAFL 21 6,9

Lain-lain 59 19,5


A 15 6,4

B 75 32,1

C 144 61,5

Komplikasi

Perdarahan varises esophagus 59 19,5

88

Ensefalopati Hepatikum 66 21,8

Karsinoma hepatoseluler 34 11,2

Sindrom hepatorenal 5 1,7

Hematemesis 79 26,1

Melena 85 28,1

Ascites 224 73,9

Peritonitis bacterial spontan 1 0,3

Gastropati HT Porta 29 12,9

Komorbid

Efusi pleura 38 12,5

Pneumonia 37 12,2

TB paru 5 1,7

Syok 7 2,3

Sepsis 19 6,3

Penyakit ginjal 10 3,3

Penyakit jantung 3 1


Tidak ada 233 76,4

Grade I-II 32 10,5

Grade III-IV 40 13,1

Ascites

Tidak ada 81 26,6

Ringan-sedang 180 59

Berat 44 14,4

Survival rate

Meninggal 60 19,8

Hidup 243 80,2

89

Lampiran 4. Tabel Tabulasi Silang Berdasarkan Survival Rate

Variabel

Status

Meninggal Hidup Jumlah

n % n % n %

Jenis kelamin

Laki-laki 39 65 166 68,3 205 67,7

Perempuan 21 35 77 31,7 98 32,3

Usia

< 31 tahun 1 1,7 9 3,7 10 3,3

31 – 40 tahun 3 5 18 7,4 21 6,9

41 – 50 tahun 15 25 64 26,3 79 26,1

51 – 60 tahun 19 31,7 85 35 104 34,3

61 – 70 tahun 15 25 44 18,1 59 19,5

> 70 tahun 7 11,7 23 9,5 30 9,9

Etiologi

Virus

HBV 35 58,3 149 61,3 184 60,7

HCV 8 13,3 47 19,3 55 18,2

HBV dan HCV 4 50 13 27,7 17 30,9

Non Virus

NAFL 3 5 18 7,4 21 6,9

Lain-lain 18 30 41 16,9 59 19,5


A 0 0 15 8,2 15 6,4

B 4 7,7 71 39 75 32,1

C 48 92,3 96 52,7 144 61,5

Komplikasi

Perdarahan varises esophagus 7 11,7 52 21,4 59 19,5

Ensefalopati hepatikum 41 68,3 25 10,3 66 21,8

Karsinoma hepatoseluler 5 8,3 29 11,9 34 11,2

Sindroma hepatorenal 2 3,3 3 1,2 5 1,7

Hematemesis 17 28,3 62 25,5 79 26,1

Melena 18 30 67 27,6 85 28,1

Ascites 47 78,3 177 72,8 224 73,9

90

Peritonitis bakterial spontan 1 1,7 0 0 1 0,3

Gastropati HT Porta 5 8,3 34 14 39 12,9

Komorbid

Efusi pleura 3 5 35 14,4 38 12,5

Pneumonia 15 25 22 9,1 37 12,2

TB paru 0 0 5 2,1 5 1,7

Syok 7 11,7 0 0 7 2,3

Sepsis 18 30 1 0,4 19 6,3

Penyakit ginjal 4 6,7 6 2,5 10 3,3

Penyakit jantung 0 0 3 1,2 3 1


Grade I-II 5 12,5 27 84,4 32 44,4

Grade III-IV 35 87,5 5 15,6 40 55,6

Ascites

Ringan-sedang 36 76,6 143 81,3 179 80,3

Berat 11 23,4 33 18,8 44 19,7

Tahun

2010 22 36,7 90 37 112 37

2011 22 36,7 101 41,6 123 40,6

2012 16 26,7 52 21,4 68 22,4

91

Tabel uji normalitas kolmogorov smirnov

Variabel p

Usia 0,193

Bilirubin Total 0,000

Albumin serum 0,246

PPT 0,000

Lama perawatan 0,000

Tabel deskriptif

Variabel N Mean SD

Usia 303 54,17 11,755

Albumin serum 259 2,345 0,6009

Variabel N Median Min. Max.

Bilirubin Total 245 1,98 0,11 36,31

PPT 226 5,3 -0,9 106,3

Lama perawatan 303 9 0 48

Tabel Chi Square Klasifikasi CHILD-PUGH terhadap Survival rate

92

Klasifikasi

CHILD-PUGH

Status

p Meninggal Hidup Jumlah

n % n % n %

A 0 0 15 8,2 15 6,4 < 0,001

B 4 7,7 71 39 75 32,1

C 48 92,3 96 52,7 144 61,5

Dari uji Chi Square antara Klasifikasi CHILD-PUGH terhadap status survival

didapatkan nilai p = < 0,001, karena p < 0,05 maka dapat disimpulkan terdapat

hubungan yang signifikan antara klasifikasi CHILD-PUGH dengan status survival.

93

Tabel sebaran usia berdasarkan survival rate

Usia

Survival Rate

p Meninggal Hidup

n (60) % n (243) %

< 31 1 1,7 9 3,7 0,761£

31 – 40 3 5 18 7,4

41 – 50 15 25 64 26,3

51 – 60 19 31,7 85 35

61 – 70 15 25 44 18,1

> 70 7 11,7 23 9,5

Keterangan :

£ Pearson Chi Square

Tabel Hubungan comorbid terhadap survival rate

Comorbid

Survival Rate

p Meninggal Hidup

n (60) % n (243) %

Efusi pleura 3 5 35 14,4 0,049*£

Pneumonia 15 25 22 9,1 0,001*£

TB paru 0 0 5 2,1 0,587¥

Syok 7 11,7 0 0 0,000*¥

Sepsis 18 30 1 0,4 0,000*¥

Penyakit ginjal 4 6,7 6 2,5 0,114¥

Penyakit jantung 0 0 3 1,2 1,000¥

Keterangan :

* Signifikan p < 0,05


94

¥ Fisher’s Exact Test

Tabel Hubungan komplikasi terhadap survival rate

Komplikasi

Survival Rate

p Meninggal Hidup

n (60) % n (243) %

Perdarahan varises Esofagus 7 11,7 52 21,4 0,088£

Ensefalopati Hepatikum 41 68,3 25 10,3 0,001*£

Karsinoma Hepatoseluler 5 8,3 29 11,9 0,429£

Sindroma Hepatorenal 2 3,3 3 1,2 0,258¥

Hematemesis 17 28,3 62 25,5 0,656£

Melena 18 30 67 27,6 0,708£

Ascites 47 78,3 177 72,8 0,385£

Peritonitis bacterial spontan 1 1,7 0 0 0,198¥

Gastropati HT Porta 5 8,3 34 14 0,241£

Keterangan :

* Signifikan p < 0,05


¥ Fisher’s Exact Test

95

Lampiran 5. Ethical Clearance

96

Lampiran 6. Surat Permohonan Peminjaman Rekam Medis

97

Lampiran 7. Dokumentasi Penelitian

98

Lampiran 8. Biodata Mahasiswa

Identitas

Nama : Ni Made Tuty Marselina

NIM : 22010110110031

Tempat / tanggal lahir : Denpasar, 23 Maret 1992

Jenis Kelamin : Perempuan

Alamat : Jl. Tanah Putih II No.8 RT03 RW02, Semarang

Nomor HP : 085737105588

E-mail : [email protected]

Riwayat Pendidikan Formal

1. SD : 1998 Lulus tahun : 2004

2. SMP : 2004 Lulus tahun : 2007

3. SMA : 2007 Lulus tahun : 2010

4. FK UNDIP : Masuk tahun 2010

mailto:[email protected]

Documents

DAFTAR PUSTAKA 1. Nurdjanah S. Sirosis hati. Dalam: Sudoyo WA